Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
JAMA, 330 (18), 1795
Always ask your healthcare professional for complete information about this product and your specific health needs
Passeri M, Cucinotta D, Bonati PA, et al
TRIUMPH-4 didn't specifically study patients with established cardiovascular disease, but TRIUMPH-3 is evaluating retatrutide in this population with results expected in 2026
GLP-1 receptor agonist medications imitate some of the effects of this hormone
Some people may notice mild swelling or tenderness at the injection site
US$ 20.83
US$ 29.22
US$ 23.82
US$ 28.64
US$ 20.80
US$ 25.48
